Summary
Anna Berdine, SVP of Marketing at Alamar Biosciences, discusses the company's mission to enable early disease detection through a high-sensitivity platform for protein biomarker analysis. She highlights the value of connecting with like-minded innovators in the Alzheimer's Moonshot Community to scale their impact and improve patient care.
Highlights
🧠 Alamar Biosciences' mission: Alamar focuses on enabling the earliest disease detection using a high-sensitivity multiplex platform for protein biomarker analysis.
🤝 Collaborating with innovators: Being part of the Alzheimer's Moonshot Community has allowed Alamar to connect with other innovators focused on transforming health outcomes.
🌍 Scaling impact: These collaborations are key to advancing patient care and scaling the company's impact in healthcare.
Are you ready to tell YOUR story? Members of our Health Moonshot Communities are leading startups with breakthrough technology-driven solutions for the world’s biggest health challenges. Exposure in StartUp Health Media to our global audience of investors and partners – including our podcast, newsletters, magazine, and YouTube channel – is available to StartUp Health Members. If you’re mission-driven, collaborative, and ready to contribute as much as you gain, you might be the perfect fit.
👉 Learn more and join today.
